| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |